Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Intravenous Immunoglobulin in Autoimmune Neuromuscular DiseasesJAMA 291:2367-2375, Dalakas,M.C., 2004